Regenerative Medicine Market by Product (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), by Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceuticals), by Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2021 – 2030
Market Definition and Dynamics:
The global regenerative medicine market is expected to reach USD 172.15 billion by 2030 from USD 13.96 billion in 2020, at a CAGR of 28.9%. Regenerative Medicine are used to regenerate, repair, replace or restore tissues and organs damaged by diseases or due to natural ageing. These medicines help in the restoration of normal cell functions and are widely used to treat various degenerative disorders such as cardiovascular disorders, orthopedic disorders and others.
The rising demand for organ transplantation and increasing awareness about the use of regenerative medicinal therapies in organ transplantation along with implementation of the 21st Century Cures Act, a U.S. law enacted by the 114th United States Congress in December 2016 are creating growth opportunities in the market. However, high cost of treatment and stringent government regulations are expected to hinder the market growth.
Market Segmentations and Scope of the Study:
The global regenerative medicine market is segmented based on product type, material, application, and geography. Based on product type, the market is classified into cell therapy, gene therapy, tissue engineering, and small molecule & biologic. Depending on material, it is categorized into synthetic material, biologically derived material, genetically engineered material, and pharmaceutical. Synthetic material is further divided into biodegradable synthetic polymer, scaffold, artificial vascular graft material, and hydrogel material. Biologically derived material is further bifurcated into collagen and xenogenic material. Genetically engineered material is further segmented into deoxyribonucleic acid, transfection vector, genetically manipulated cell, three-dimensional polymer technology, transgenic, fibroblast, neural stem cell, and gene-activated matrices. Pharmaceutical is further divided into small molecule and biologic. By application, it is categorized into cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. Geographically, it is analyzed across four regions, i.e., North America, Europe, Asia-Pacific, and RoW.
The key players operating in the global regenerative medicine market include Integra Lifesciences Corporation, AbbVie Inc., Merck KGaA, Medtronic, Thermo Fisher Scientific Inc., Smith+Nephew, Becton, Dickinson and Company, Baxter International Inc, Cook Biotech, and Organogenesis Inc., among others.
KEY MARKET SEGMENTS:
Global Regenerative Medicine Market- By Product Type
Small Molecule & Biologic
· Global Regenerative Medicine Market- By Material
Biodegradable Synthetic Polymer
Artificial Vascular Graft Material
Biologically Derived Material
Genetically Engineered Material
Deoxyribonucleic Acid Transfection Vector
Genetically Manipulated Cell
Three-Dimensional Polymer Technology
Neural Stem Cell
· Global Regenerative Medicine Market- By Application
· Global Regenerative Medicine Market- By Geography
Rest of Europe
Rest of Asia-Pacific
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook